| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.05. | Incyte to Deploy Edison Scientific's AI Scientist Kosmos for R&D | ||
| 19.05. | ATB Therapeutics Names Mark Throsby as CEO | ||
| 19.05. | Vistagen Taps Dr. Angel Angelov as Chief Medical Officer | ||
| 19.05. | Hansa Biopharma Signs IDEFIRIX Licensing Deal With SERB | ||
| 19.05. | Helio Genomics Partners with Syneos Health to Drive Awareness & Adoption of HelioLiver | ||
| 18.05. | AstraZeneca Hypertension Treatment Baxfendy Approved by FDA | ||
| 18.05. | Orca Bio Taps Bijan Nejadnik as New Chief Medical Officer | ||
| 18.05. | Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9B | ||
| 18.05. | AstraZeneca, Daiichi Sankyo's Enhertu Gets New US Approval for Two HER2-Positive Breast Cancer Indications | ||
| 18.05. | ProtaGene Teams With MilliporeSigma on End-to-End Testing | ||
| 18.05. | Triana Biomedicines Taps Dr. Mohan Bala as Chief Operating Officer | ||
| 18.05. | Piramal Pharma Solutions, Botanix Partner to Support Drug Substance Development | ||
| 18.05. | FDA Approves First Simponi Biosimilars in U.S. | ||
| 18.05. | Parabilis Medicines, Regeneron Partner to Advance Novel Antibody-Helicon Conjugates | ||
| 15.05. | Veracyte Gains Medicare Coverage for Muscle-Invasive Bladder Cancer Recurrence Monitoring Test | ||
| 15.05. | Valar Labs Gets FDA Breakthrough Device Nod for Vesta Bladder Cancer Risk Test | ||
| 15.05. | Telix to Explore PSMA-PET Imaging in Collaborations with EDAP TMS and Profound | ||
| 14.05. | Terumo BCT, Steminent Join to Accelerate Late-Stage Clinical Manufacturing for Mesenchymal Stem Cell Therapies | ||
| 14.05. | Nuvation Bio Completes IBTROZI Manufacturing Tech Transfer to Thermo Fisher | ||
| 14.05. | Iterative Health Acquires Three Texas Cardiology Sites from NextStage Clinical Research | ||
| 14.05. | Degron Therapeutics Closes $40M Series A Extension Advancing Molecular Glue Degrader | ||
| 14.05. | OnCusp Therapeutics Taps Anthony Kim as Chief Financial Officer | ||
| 14.05. | Fosun Pharma, AriBio Sign Exclusive Global Option Agreement | ||
| 14.05. | IQVIA, Kexing Biopharm Expand Collaboration to Advance Biosimilar Development | ||
| 13.05. | Pfizer's Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors |